| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/24/2009 | US20090318334 Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease |
| 12/24/2009 | US20090318333 Modified Metallothioneins and Methods for Screening and Treatment of Diseases Associated With Oxidative Stress |
| 12/24/2009 | US20090318332 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 12/24/2009 | US20090318331 Oral insulin therapies and protocol |
| 12/24/2009 | US20090318330 Combination of amino acid solution and a gelatin derivative for inhibiting renal up-take |
| 12/24/2009 | US20090318329 Methods for assessing suitability of cancer patients for treatment with histone deacetylase inhibitors |
| 12/24/2009 | US20090317868 Rapidly Cleavable Sumo Fusion Protein Expression System for Difficult to Express Proteins |
| 12/24/2009 | US20090317538 Biologically active implants |
| 12/24/2009 | US20090317478 Method of preparing covered porous biodegradable polymer microspheres for sustained-release drug delivery and tissue regeneration |
| 12/24/2009 | US20090317462 Peptide pharmaceutical for oral delivery |
| 12/24/2009 | US20090317457 Anti-inflammatory and wound healing effects of lymphoid thymosin b-4 |
| 12/24/2009 | US20090317454 Body or plant part dressing |
| 12/24/2009 | US20090317453 Transdermal and topical administration of drugs using basic permeation enhancers |
| 12/24/2009 | US20090317438 Whole blood-derived coagulum device for treating bone defects |
| 12/24/2009 | US20090317428 Immunogenic T-Helper Epitopes From Human Tumour Antigens and Immunotherapeutic Methods Using Said Epitopes |
| 12/24/2009 | US20090317415 Hpv vaccine comprising peptides from host cell proteins |
| 12/24/2009 | US20090317410 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 12/24/2009 | US20090317398 a labeled polyclonal antibody, monoclonal antibody or antigen-binding fragment which preferentially binds to a polypeptide that chemoattracts peripheral blood monocytes or T-cells; proteins which control development, differentiation, trafficking and physiology of mammalian cells; immunology |
| 12/24/2009 | US20090317397 Soluble CTLA4 mutant molecules and uses thereof |
| 12/24/2009 | US20090317395 Antimicrobial Peptide Derived from Galanin Message Associated Peptide (GMAP) |
| 12/24/2009 | US20090317394 Vascular endothelial growth factor-2 |
| 12/24/2009 | US20090317393 Method of modifying glucose activity using polypeptides selectively expressed in fat tissue |
| 12/24/2009 | US20090317391 Cancer Related Genes (PTPE) |
| 12/24/2009 | US20090317389 Fusion molecules and methods for treatment of immune diseases |
| 12/24/2009 | US20090317388 Tl1a in treatment of disease |
| 12/24/2009 | US20090317385 Methods Using Immunomodulatory Compounds for Modulating Level of CD59 |
| 12/24/2009 | US20090317381 Clearance of abnormal iga1 in iga1 deposition diseases |
| 12/24/2009 | US20090317380 Use of prion conversion modulating agents |
| 12/24/2009 | US20090317378 Antimicrobial composition and uses thereof |
| 12/24/2009 | US20090317377 Therapy procedure for drug delivery for trigeminal pain |
| 12/24/2009 | US20090317376 Compositions And Methods For Lipo Modeling |
| 12/24/2009 | US20090317375 Von willebrand factor (vwf) inhibitors for treatment or prevention of infarction |
| 12/24/2009 | US20090317374 Composition containing arazyme for the prevention and treatment of cancer |
| 12/24/2009 | US20090317373 Inhibition of the Anti-FVIII Immune Response |
| 12/24/2009 | US20090317372 Small molecules for the reduction of high blood glucose level |
| 12/24/2009 | US20090317371 Method, Composition, and Device, for the Treatment of Amylase Malfunctions / Inactivity in Association with Saccharides (Mainly Polysaccharides) Based Diseases |
| 12/24/2009 | US20090317368 B7-h1, a novel immunoregulatory molecule |
| 12/24/2009 | US20090317364 Novel compositions for prevention and treatment of mastitis and metritis |
| 12/24/2009 | US20090317363 Cytokine Derivatives |
| 12/24/2009 | US20090317361 Carba-nucleoside analogs for antiviral treatment |
| 12/24/2009 | US20090317360 Anti-viral inhibitors and methods of use |
| 12/24/2009 | US20090317359 2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines and methods of their use as inhibitors of raf kinase |
| 12/24/2009 | US20090317358 Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities |
| 12/24/2009 | US20090317357 Methods for treating or preventing autoimmune disease using histamine h1 receptor-blocking agents |
| 12/24/2009 | US20090317343 Personal Care Compositions Containing Silicone Elastomer Gels |
| 12/24/2009 | US20090317332 Human g protein-coupled receptor and modulators thereof for the treatment of obesity and conditions related thereto |
| 12/24/2009 | DE202008015430U1 Zusammensetzung zur Behandlung von Verdauungsstörungen Composition for the treatment of digestive disorders |
| 12/23/2009 | WO2009155585A1 N utragenomics |
| 12/23/2009 | WO2009155556A2 Crkl targeting peptides |
| 12/23/2009 | WO2009155504A2 Methods for the modulation of angiogenesis |
| 12/23/2009 | WO2009155489A2 Compositions and methods for treating influenza |
| 12/23/2009 | WO2009155257A1 Glucagon analogs exhibiting enhanced solubility and stability physiological ph buffers |
| 12/23/2009 | WO2009155097A1 Natural product inhibitors of 3dg |
| 12/23/2009 | WO2009155064A1 Bifunctional molecules for inhibiting hiv entry |
| 12/23/2009 | WO2009155055A2 Methods of effecting wnt signaling through dkk structural analysis |
| 12/23/2009 | WO2009155026A1 Method and composition for a protein transduction technology and its applications |
| 12/23/2009 | WO2009154988A2 Agr-mediated inhibition and dispersal of biofilms |
| 12/23/2009 | WO2009154737A1 Boronate ester compounds and pharmaceutical compositions thereof |
| 12/23/2009 | WO2009154697A2 Disc-1 pathway activators in the control of neurogenesis |
| 12/23/2009 | WO2009154452A1 Parvoviral capsid with incorporated Gly-Ala repeat region |
| 12/23/2009 | WO2009154447A1 Heat-stable, aqueous lactoferrin composition and its preparation and use |
| 12/23/2009 | WO2009154264A1 Peptide |
| 12/23/2009 | WO2009154237A1 Stabilizer for lymph vessel |
| 12/23/2009 | WO2009154169A1 Peptide derivative and composition for promoting tear secretion comprising the same |
| 12/23/2009 | WO2009153992A1 Cdca1 epitope peptides and vaccines containing the same |
| 12/23/2009 | WO2009153960A1 Glycosylated glp-1 peptide |
| 12/23/2009 | WO2009153573A1 Methods and compositions |
| 12/23/2009 | WO2009153459A1 Combination of a tiliroside and a peptide |
| 12/23/2009 | WO2009153418A1 Harp peptides inhibiting tumour growth |
| 12/23/2009 | WO2009153336A1 Cd5 pharmaceutical compositions for the treatment of infectious and inflammatory processes of fungal origin |
| 12/23/2009 | WO2009152944A1 Modified erythropoietin (epo)polypeptides that exhibit increased protease resistance and pharmaceutical compositions thereof |
| 12/23/2009 | WO2009152610A1 Interleukin-2/soluble tgf-beta type ii receptor b conjugates and methods and uses thereof |
| 12/23/2009 | WO2009134130A3 Treatment of bleeding with low half-life fibrinogen |
| 12/23/2009 | WO2009130256A3 Tat protein for preventing or treating aids |
| 12/23/2009 | WO2009129502A3 Immunotherapies employing self-assembling vaccines |
| 12/23/2009 | WO2009129498A3 Substance p and analogs thereof as a cancer immunogenic composition adjuvant |
| 12/23/2009 | WO2009129408A3 Compositions and methods for treating pathologic angiogenesis and vascular permeability |
| 12/23/2009 | WO2009125424A3 Peptidomimetics with glucagon antagonistic and glp-1 agonistic activities |
| 12/23/2009 | WO2009121069A3 Compositions and methods for the preparation of nanoemulsions |
| 12/23/2009 | WO2009120831A3 Novel n-and c-terminal substituted -antagonistic analogs of human gh-rh |
| 12/23/2009 | WO2009117365A3 Vaccine compositions for inducing immune responses against components of drusen |
| 12/23/2009 | WO2009116894A3 Oxygen-transferring blood substitute and a pharmaceutical composition (variants) |
| 12/23/2009 | WO2009115548A3 Method for the treatment of ischemia reperfusion injury |
| 12/23/2009 | WO2009114462A3 Local delivery of chemotherapeutic agents to skeletal metastases |
| 12/23/2009 | WO2009102895A3 Method to predict response to pharmacological chaperone treatment of diseases |
| 12/23/2009 | WO2009100035A3 Interleukin-21 (il-21) and il-21 receptor (il-21r) modulation of regulatory t cells and forkhead box p3 (foxp3) |
| 12/23/2009 | WO2009095562A3 Biomaterial for the controlled delivery of ingredients |
| 12/23/2009 | WO2009079566A3 Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production |
| 12/23/2009 | WO2009074969A3 Spingosine-1-phosphate, analogues and antagonists for use as medicaments |
| 12/23/2009 | WO2009054873A3 Anti-rantes antibodies and methods of use thereof |
| 12/23/2009 | WO2009049568A3 Anisotropic implant and its method of production |
| 12/23/2009 | WO2008091643A3 Evaluating synergy of combinations comprising an antibody in immune suppressive pathways concurrent to immunotherapy |
| 12/23/2009 | WO2001000790A9 Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| 12/23/2009 | WO2000015247A8 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 12/23/2009 | EP2135953A1 Novel hemopoietin receptor protein, Nr. 10 |
| 12/23/2009 | EP2135952A2 Cripto antagonism of activin and TGF-beta signaling |
| 12/23/2009 | EP2135951A1 Transgenic rodents having ngf beta gene mutants and its preparation methods, the preparation methods of the corresponding mutant proteins and the resulting mutant proteins |
| 12/23/2009 | EP2135948A2 ENA nucleic acid drugs modifying splicing in mRNA precursor |
| 12/23/2009 | EP2135623A1 Method of treatment of a BCL-2 disorder using BCL-2 antisense oligomers |
| 12/23/2009 | EP2135618A2 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |